Pfizer’s Bleak Forecast Dims Hope for Rebound After 2023 Rout
Pfizer Inc. shares are set to enter the new year trading near the lowest level in a decade, yet Wall Street is increasingly hesitant to bet on a recovery after the drugmaker issued a disappointing 2024 outlook this week. • None Citi Shuts Muni Business That Once Was Envy of Rivals • None Owner of…
#pfizerinc #nonecitishuts #philippines #seageninc #pfizer #wellsfargo #mohitbansal #jpmorgan #chrisschott #wellsfargosbansal